Annual EBITDA
-$11.43 M
-$10.57 M-1238.11%
31 December 2023
Summary:
Telomir Pharmaceuticals Common Stock annual earnings before interest, taxes, depreciation & amortization is currently -$11.43 million, with the most recent change of -$10.57 million (-1238.11%) on 31 December 2023. During the last 3 years, it has fallen by -$11.29 million (-8175.74%). TELO annual EBITDA is now -8175.74% below its all-time high of -$138.10 thousand, reached on 01 December 2021.TELO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$5.99 M
-$4.54 M-313.44%
30 September 2024
Summary:
Telomir Pharmaceuticals Common Stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$5.99 million, with the most recent change of -$4.54 million (-313.44%) on 30 September 2024. Over the past year, it has dropped by -$5.04 million (-527.82%). TELO quarterly EBITDA is now -8445.93% below its all-time high of -$70.10 thousand, reached on 01 June 2022.TELO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$17.92 M
-$5.04 M-39.09%
30 September 2024
Summary:
Telomir Pharmaceuticals Common Stock TTM earnings before interest, taxes, depreciation & amortization is currently -$17.92 million, with the most recent change of -$5.04 million (-39.09%) on 30 September 2024. Over the past year, it has dropped by -$14.57 million (-434.88%). TELO TTM EBITDA is now -25465.19% below its all-time high of -$70.10 thousand, reached on 01 June 2022.TELO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TELO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1238.1% | -527.8% | -434.9% |
| 3 y3 years | -8175.7% | - | - |
| 5 y5 years | - | - | - |
TELO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8175.7% | at low | -8445.9% | +30.1% | <-9999.0% | at low |
| 5 y | 5 years | -8175.7% | at low | -8445.9% | +30.1% | <-9999.0% | at low |
| alltime | all time | -8175.7% | at low | -8445.9% | +30.1% | <-9999.0% | at low |
Telomir Pharmaceuticals Common Stock EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.99 M(+313.4%) | -$17.92 M(+39.1%) |
| June 2024 | - | -$1.45 M(-24.4%) | -$12.88 M(+0.2%) |
| Mar 2024 | - | -$1.92 M(-77.6%) | -$12.86 M(+12.5%) |
| Dec 2023 | -$11.43 M | -$8.57 M(+797.7%) | -$11.43 M(+241.1%) |
| Sept 2023 | - | -$954.20 K(-33.1%) | -$3.35 M(+27.4%) |
| June 2023 | - | -$1.43 M(+195.4%) | -$2.63 M(+106.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$482.90 K(-0.9%) | -$1.27 M(+61.1%) |
| Dec 2022 | -$854.10 K(+518.5%) | - | - |
| Dec 2022 | - | -$487.10 K(+108.6%) | -$790.70 K(+160.4%) |
| Sept 2022 | - | -$233.50 K(+233.1%) | -$303.60 K(+333.1%) |
| June 2022 | - | -$70.10 K | -$70.10 K |
| Dec 2021 | -$138.10 K | - | - |
FAQ
- What is Telomir Pharmaceuticals Common Stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Telomir Pharmaceuticals Common Stock?
- What is Telomir Pharmaceuticals Common Stock annual EBITDA year-on-year change?
- What is Telomir Pharmaceuticals Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Telomir Pharmaceuticals Common Stock?
- What is Telomir Pharmaceuticals Common Stock quarterly EBITDA year-on-year change?
- What is Telomir Pharmaceuticals Common Stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Telomir Pharmaceuticals Common Stock?
- What is Telomir Pharmaceuticals Common Stock TTM EBITDA year-on-year change?
What is Telomir Pharmaceuticals Common Stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of TELO is -$11.43 M
What is the all time high annual EBITDA for Telomir Pharmaceuticals Common Stock?
Telomir Pharmaceuticals Common Stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$138.10 K
What is Telomir Pharmaceuticals Common Stock annual EBITDA year-on-year change?
Over the past year, TELO annual earnings before interest, taxes, depreciation & amortization has changed by -$10.57 M (-1238.11%)
What is Telomir Pharmaceuticals Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of TELO is -$5.99 M
What is the all time high quarterly EBITDA for Telomir Pharmaceuticals Common Stock?
Telomir Pharmaceuticals Common Stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$70.10 K
What is Telomir Pharmaceuticals Common Stock quarterly EBITDA year-on-year change?
Over the past year, TELO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$5.04 M (-527.82%)
What is Telomir Pharmaceuticals Common Stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of TELO is -$17.92 M
What is the all time high TTM EBITDA for Telomir Pharmaceuticals Common Stock?
Telomir Pharmaceuticals Common Stock all-time high TTM earnings before interest, taxes, depreciation & amortization is -$70.10 K
What is Telomir Pharmaceuticals Common Stock TTM EBITDA year-on-year change?
Over the past year, TELO TTM earnings before interest, taxes, depreciation & amortization has changed by -$14.57 M (-434.88%)